GSDME and neoplasm: At the time of this writing, Zhang et al. revealed that GSDME (also known as DFNA5) can inhibit tumor growth by enhancing phagocytosis of macrophages, as well as increasing the number and functions of natural-killer (NK) cells and cytotoxic T lymphocytes (Zhang et al., 2020).